TGTX

Tg Therapeutics Stock Analysis

AI Rating

Good
  • Quality5/10
  • Growth↑ 9/10
  • Value↓ 2/10
Tg Therapeutics sales and earnings growth
TGTX Growth
Great
  • Revenue Y/Y↑ 78.29%
  • EPS Y/Y↑ 1092.59%
  • FCF Y/Y↑ 76.77%
Tg Therapeutics gross and profit margin trends
TGTX Profitability
Great
  • Gross margin ↑ 83.10%
  • EPS margin↑ 66.00%
  • ROIC 5Y↓ 0.99%
Tg Therapeutics net debt vs free cash flow
TGTX Risk
Good
  • Debt / Equity↓ 1.3
  • Debt / FCF↑ 21.7
  • Interest coverage↑ 5.4

Tg Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

↗ More Biotechnology stocks